Valiant Laboratories Ltd
Valiant Laboratories Ltd Share Price Today: Live Updates & Key Insights
Get insights on Valiant Laboratories Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Valiant Laboratories Ltd Share Price Chart
VALIANTLAB at 10 Jul 2026 06:33 PM Pharmaceuticals
62.08 -0.08(-0.13%)
Lowest Today 60.17
Highest Today 63.69
Today's Open 62.99
Prev. Close 62.16
52 Week High 115.54
52 Week Low 49.51
Valiant Laboratories Ltd Fundamentals
Traded Volume: 15,706
Market Cap(Cr): 337.17
Avg Traded Price 62.18
1 Year return -41.98%
Upper Circuit 63.7
Lower Circuit 60.2
P/E TTM -103.00
P/B Ratio 1.086
Traded Value(Cr) 9.75
EPS TTM -0.603
Book value/Share 57.240
Dividend Yield 1Y 0.00%
Valiant Laboratories Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Valiant Laboratories Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Valiant Laboratories Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -4.21%
1M -14.75%
3M +7.57%
1Y -41.98%
YTD -9.62%
Valiant Laboratories Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Valiant Laboratories Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 13893.00
Day Before Yesterday 16447.00
1W Avg 13009.00
1M Avg 21224.67
3M Avg 44774.98
Valiant Laboratories Ltd Technical Details
Valiant Laboratories Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 60
Support 2 58
Support 3 57
Pivot Point : 62
Resistance 1 64
Resistance 2 66
Resistance 3 67
Valiant Laboratories Ltd Corporate Actions
Valiant Laboratories Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Valiant Laboratories Ltd’s capital allocation strategies.
All
Ex-Date 18-Jul-2025 Type R Description /share@1:4% Record Date 19-Jul-2025 Ratio 1:4
Dividends
No Dividend has been declared by VALIANTLAB
Bonus
No Bonus has been declared by VALIANTLAB
Splits
No Split has been declared by VALIANTLAB
Others
Ex-Rights Date 18-Jul-2025 Premium(Rs.) 65.00 Ratio 1:4
Valiant Laboratories Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Valiant Laboratories Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Valiant Laboratories Ltd's relative performance and valuation against major competitors.
Stock Name Haleos Labs Limited ₹1596.60 (+3.22%) M. Cap (Cr) 4.83 1 Yr Return (%) +31.82% P/E (TTM) 27.88 PB Ratio 2.26
Stock Name Albert David Ltd ₹701.00 (+0.65%) M. Cap (Cr) 4.00 1 Yr Return (%) -23.91% P/E (TTM) -267.66 PB Ratio 1.02
Stock Name Aptus Pharma Ltd ₹224.00 (+1.93%) M. Cap (Cr) 3.84 1 Yr Return (%) NaN% P/E (TTM) 83.15 PB Ratio 16.45
Stock Name Valiant Laboratories Ltd ₹62.08 (-0.13%) M. Cap (Cr) 3.37 1 Yr Return (%) -41.98% P/E (TTM) -102.91 PB Ratio 1.08
Stock Name Medicamen Biotech Ltd ₹245.35 (-0.02%) M. Cap (Cr) 3.33 1 Yr Return (%) -37.94% P/E (TTM) 30.63 PB Ratio 1.21
Stock Name Medico Remedies Ltd ₹39.71 (+1.59%) M. Cap (Cr) 3.30 1 Yr Return (%) -5.36% P/E (TTM) 25.13 PB Ratio 4.37
Stock Name Trident Lifeline Ltd ₹262.50 (-0.61%) M. Cap (Cr) 3.13 1 Yr Return (%) -2.51% P/E (TTM) 16.29 PB Ratio 3.21
Valiant Laboratories Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Valiant Laboratories Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 -13.81 Mar 2025 -21.90 Mar 2024 48.78 Mar 2023 22.96 Mar 2022 2.25
PARTICULARS Investing Activities Mar 2026 -8.09 Mar 2025 24.97 Mar 2024 -182.73 Mar 2023 -21.18 Mar 2022 -12.24
PARTICULARS Financing Activities Mar 2026 20.17 Mar 2025 -0.50 Mar 2024 135.80 Mar 2023 -1.53 Mar 2022 6.18
PARTICULARS Net Cash Flow Mar 2026 -1.73 Mar 2025 2.57 Mar 2024 1.85 Mar 2023 0.24 Mar 2022 -3.81
Valiant Laboratories Ltd Shareholding Pattern
This shows the ownership breakdown of Valiant Laboratories Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 74.94%
Public 24.87%
Other Institutions 0.0%
FII 0.2%
Mutual Funds N/A%
About Valiant Laboratories Ltd
Valiant Laboratories Limited was originally formed as a Partnership Firm as `M/s. Bharat Chemicals' through deed of partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Company to Valiant Laboratories Limited via Certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually, commenced manufacturing of Paracetamol by late 1982. Paracetamol (Scientific name: Acetaminophen or para-hydroxyacetanilide - C8H9NO2), is one of the most commonly taken analgesic worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of customers.Paracetamol is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms. Paracetamol is often found combined with other drugs in many over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products. Presently, the Company is engaged in manufacturing and dealing in Pharmaceuticals and specility chemicals. The manufacturing facility is located at Tarapur Industrial Area, Boisar in the State of Maharashtra, with an annual installed capacity of 9,000 MTPA. Within the Manufacturing Facility located at Tarapur Industrial Area, Palghar, Maharashtra, the Company has an in-house R&D infrastructure which is equipped with analytical laboratory and infrastructure for developmental activities in existing product. The Company is promoted by Shantilal Shivji Vora, Director and Dhanvallabh Ventures LLP (DVL). In July, 2022 the Company formed its wholly owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) to diversify the business activities.The Company launched a public issue comprising a fresh issue of 10,890,000 equity shares of Rs 10 each by raising funds of Rs 15.24 crore on October 03, 2023.Company enhanced the manufacturing capacity of the Tarapur plant from 750 MT to 900 MT per month in FY25.
Chairman & Independent Directo
Mulesh Manilal Savla
Registered office 104 Udyog Kshetra Mulund, Goregaon Link Rd Mulund West, Mumbai, Maharashtra, 400080
FAX :+91 22 49712001
Background
Incorporation Year 2021
Face Value ₹10.00
Market Lot 1
FAQs on Valiant Laboratories Ltd
How to buy Valiant Laboratories Ltd shares?
To buy Valiant Laboratories Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Valiant Laboratories Ltd?
The company has a market capitalization of ₹337.17.
What is the PE & PB ratio of Valiant Laboratories Ltd?
PE is -103 and PB is 1.086.
What is the Valiant Laboratories Ltd dividend for 2025–26?
For the 2025–26 financial year, Valiant Laboratories Ltd declared a final dividend of 0.00% per share.